News & partners

Dianosic is a biotech focused on the development of novel solutions integrated drug and
delivery system for the localized treatment of patients with chronic rhinitis and chronic rhinosinusitis.

Latest news

Sep 21, 2020

Marc Augustin: B SMART Interview

See more
Jun 22, 2020

The Medtech Strategist x Dianosic

See more
Apr 23, 2020

Talent 4 boards x Dianosic

See more
Apr 23, 2020

Finyear x Dianosic – funding

See more

They support us

Our investors

We built a solid network of partners to support company funding and growth.

Fondation Force
Bpi France
Banque Populaire Rives de Paris
Caisse d’épargne Grand Est